A pilot study evaluating the impact of ibudilast on prevention of chemotherapy-induced neurotoxicity and evaluating pharmacokinetics in metastatic gastro-intestinal cancer patients receiving oxaliplatin
Phase of Trial: Phase I
Latest Information Update: 07 Aug 2019
Price : $35 *
At a glance
- Drugs Ibudilast (Primary) ; Capecitabine; Fluorouracil; Oxaliplatin
- Indications Chemotherapy-induced damage; Peripheral neuropathies
- Focus Therapeutic Use
- 07 Aug 2019 Status changed from recruiting to completed.
- 29 Aug 2018 Status changed from planning to recruiting.
- 04 Apr 2018 New trial record